Nachman Norwood & Parrott’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$2.43M Sell
13,522
-35
-0.3% -$6.39K 0.25% 81
2021
Q1
$2.62M Sell
13,557
-61
-0.4% -$11.7K 0.29% 76
2020
Q4
$2.75M Buy
13,618
+3
+0% +$621 0.32% 63
2020
Q3
$2.86M Buy
13,615
+67
+0.5% +$14.9K 0.39% 52
2020
Q2
$2.97M Sell
13,548
-1,859
-12% -$371K 0.49% 38
2020
Q1
$2.67M Buy
15,407
+75
+0.5% +$12.4K 0.54% 39
2019
Q4
$2.35M Hold
15,332
0.39% 58
2019
Q3
$2.33M Hold
15,332
0.41% 56
2019
Q2
$2.35M Buy
15,332
+30
+0.2% +$4.58K 0.42% 52
2019
Q1
$2.46M Hold
15,302
0.46% 50
2018
Q4
$2.36M Buy
+15,302
New +$2.38M 0.49% 45

Other funds holding CLX

Nachman Norwood & Parrott's CLX Position: Q2 2021 in Review

Nachman Norwood & Parrott reduced its Clorox (CLX) stake by 0.26% in Q2 2021, selling an estimated $6.39K and leaving 13,522 shares worth $2.43M. The position accounts for 0.25% of the portfolio, ranked #81.

Nachman Norwood & Parrott first reported a position in CLX in Q4 2018 and has held it in 11 quarters since. The position peaked at $2.97M in Q2 2020. 1,169 funds tracked by Wall St. Rank hold CLX as of Q2 2021.

  • Nachman Norwood & Parrott held 13,522 shares of Clorox worth $2.43M as of Q2 2021.
  • Nachman Norwood & Parrott sold 35 Clorox shares in Q2 2021, an estimated $6.39K.
  • Clorox made up 0.25% of Nachman Norwood & Parrott's portfolio in Q2 2021, its #81 holding.
  • Nachman Norwood & Parrott first reported a position in Clorox in Q4 2018 and has held it in 11 quarters since.
  • Nachman Norwood & Parrott's Clorox position peaked at $2.97M in Q2 2020.
  • 1,169 funds tracked by Wall St. Rank held Clorox as of Q2 2021.

Based on Nachman Norwood & Parrott's 13F filing for Q2 2021, filed 13 Aug 2021.